Advances in Clinical Chemistry, Volume 127 explores physiologic and pathophysiologic biochemistry in both general and clinical chemistry. Complex molecular pathways are elucidated using historical, current, and emerging technologies such as biosensor design, metabolomics, and proteomics. Chapters in this new release include The Cancer Microbiome, Metabolomics of Nephrotic Syndrome, Advances in Biomimetic Sensor Technology, Gel electrophoresis-based proteoform separation and analysis, Advances in blood microsampling technology for cancer biomarker detection, and MDDB: A public databank of host microRNAs in Tuberculosis diagnosis.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. Contributors - p. xi 6. Preface - p. xiii 7. Chapter One: The cancer microbiome - p. 1 8. Chapter Two: Metabolomics of nephrotic syndrome - p. 63 9. Chapter Three: Advances in biomimetic sensor technology - p. 85 10. Chapter Four: Gel electrophoresis-based proteoform separation and analysis - p. 119 11. Chapter Five: Advances in blood microsampling technology for cancer biomarker detection - p. 173 12. Chapter Six: MDDB: A public databank of host microRNAs in Tuberculosis diagnosis - p. 221 13. Index - p. 255
Advances in Clinical Chemistry, Volume 127 explores physiologic and pathophysiologic biochemistry in both general and clinical chemistry. Complex molecular pathways are elucidated using historical, current, and emerging technologies such as biosensor design, metabolomics, and proteomics. Chapters in this new release include The Cancer Microbiome, Metabolomics of Nephrotic Syndrome, Advances in Biomimetic Sensor Technology, Gel electrophoresis-based proteoform separation and analysis, Advances in blood microsampling technology for cancer biomarker detection, and MDDB: A public databank of host microRNAs in Tuberculosis diagnosis.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. Contributors - p. xi 6. Preface - p. xiii 7. Chapter One: The cancer microbiome - p. 1 8. Chapter Two: Metabolomics of nephrotic syndrome - p. 63 9. Chapter Three: Advances in biomimetic sensor technology - p. 85 10. Chapter Four: Gel electrophoresis-based proteoform separation and analysis - p. 119 11. Chapter Five: Advances in blood microsampling technology for cancer biomarker detection - p. 173 12. Chapter Six: MDDB: A public databank of host microRNAs in Tuberculosis diagnosis - p. 221 13. Index - p. 255
